| Ming Cui, Ya Hu, Zejian Zhang, Tianqi Chen, Menghua Dai, Qiang Xu, Junchao Guo, Taiping Zhang, Quan Liao, Jun Yu, Yupei Zha. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm. Signal transduction and targeted therapy. vol 8. issue 1. 2023-10-17. PMID:37848412.
||these findings hold significant clinical implications, providing valuable insights for pcn decision-making, and potentially offering therapeutic targets for pcn treatment.
| Zhenglin Dong, Xiahan Chen, Zhaorui Cheng, Yuanbo Luo, Min He, Tao Chen, Zijie Zhang, Xiaohua Qian, Wei Che. Differential diagnosis of pancreatic cystic neoplasms through a radiomics-assisted system. Frontiers in oncology. vol 12. 2023-01-02. PMID:36591475.
||in conclusion, our research constructed an end-to-end powerful pcn differential diagnosis system based on radiomics method, which could assist decision-making in clinical practice.
| Rajesh Ramanathan, Amr I Al Abbas, Travis Mason, Luke G Wolfe, Brian J Kapla. Age-related risks of complications after distal pancreatectomy for neuroendocrine and cystic neoplasms. HPB : the official journal of the International Hepato Pancreato Biliary Association. vol 21. issue 7. 2020-04-14. PMID:30528554.
||this study analyzes the short-term complications associated with distal pancreatectomy (dp) for pnet and pcn in older adults to inform clinical decision-making.
| Wentao Zhou, Yefei Rong, Tiantao Kuang, Yadong Xu, Xiaojing Shen, Yuan Ji, Wenhui Lou, Dansong Wan. The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms. Oncotarget. vol 8. issue 70. 2019-11-20. PMID:29383181.
||the treatment decision-making of mucinous pancreatic cystic neoplasm (pcn) has become a common clinical problem since the diagnostic accuracy of current tests in identifying malignancies in pancreatic cysts is limited.